MedTrace Logo

Colonoscopy Using Nitrous Oxide- A Pilot Study in the USA

NCT04305158 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2024-04-11

No results posted yet for this study

Summary

Colon cancer is the second most common cancer in men and the third most common cancer in women worldwide. The clinical objectives of administering sedation for GI endoscopy are to relieve patient anxiety and discomfort and to improve the outcome of the examination. Use of N2O could potentially provide an alternate safe and cheap option for patients who do not prefer IV sedation for colonoscopy

Conditions

  • Nitrous Oxide

Interventions

DRUG

Nitrous Oxide

Patient receiving nitrous oxide are evaluated for success of the procedure

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Stephan Dehmel, MD · University of Arkansas

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-28
Primary Completion
2023-08-10
Completion
2023-08-10
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04305158 on ClinicalTrials.gov